Evidence map›Paper›PMID 35207238›Full record

ArticleJournal of clinical medicine2022

Efficacy and Safety of the Hexanic Extract of

Antonio Alcaraz, Mauro Gacci, Vincenzo Ficarra, José Medina-Polo, Andrea Salonia, Jesús M Fernández-Gómez, Alexandru Ciudin, David Castro-Díaz, Alfredo Rodríguez-Antolín, Joaquín Carballido-Rodríguez and 10 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Antonio AlcarazUrology Department, Hospital Clínic, Universitat de Barcelona, IDIBAPS, 08036 Barcelona, Spain.
Mauro GacciUnit of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, Careggi University Hospital (AOUC), University of Florence, 50134 Florence, Italy.
Vincenzo FicarraDepartment of Human and Pediatric Pathology "Gaetano Barresi", Urology Section, University of Messina, 98125 Messina, Italy.
José Medina-PoloUrology Department, Research Institute Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.ORCID 0000-0003-3626-8669
Andrea SaloniaDivision of Experimental Oncology, URI, IRCCS Ospedale San Raffaele, University Vita-Salute San Raffaele, 20132 Milan, Italy.
Jesús M Fernández-GómezUrology Department, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Alexandru CiudinUrology Department, Hospital de Mollet, 08100 Mollet, Spain.
David Castro-DíazUrology Department, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
Alfredo Rodríguez-AntolínUrology Department, Research Institute Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.
Joaquín Carballido-RodríguezUrology Department, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Majadahonda, Spain.
José M Cózar-OlmoUrology Department, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain.
Santiago Búcar-TerradesUrology Department, Hospital El Pilar, Quirón Salud, 08006 Barcelona, Spain.
Noemí Pérez-LeónGran Sol Primary Care Center, 08914 Badalona, Spain.
Francisco J Brenes-BermúdezSEMERGEN Nefro-Urology Working Group, 08338 Premià de Dalt, Spain.
José M Molero-GarcíaSan Andrés Primary Care Center, 28021 Madrid, Spain.
Antonio Fernández-Pro LedesmaMenasalbas Primary Care Center, 45128 Toledo, Spain.
Michael HerdmanInsight Consulting and Research, 08301 Mataró, Spain.
José ManasanchPierre Fabre Ibérica S.A., 08005 Barcelona, Spain.ORCID 0000-0003-3633-8778
Javier C AnguloClinical Department, Universidad Europea de Madrid, 28905 Getafe, Spain.ORCID 0000-0002-1735-8792
On Behalf Of The Qualiprost Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated changes in symptoms and quality of life (QoL) in men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) receiving the hexanic extract of

Indexed as

adverse effectsBPHhexanic extract of Serenoa repensmoderate-severe LUTSquality of lifesexual functiontolerabilitywatchful waiting

Identifiers

PMID35207238
PMCPMC8878824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.